RB
Riyaz Bashir Khan
About Riyaz Bashir Khan
Riyaz Bashir Khan has 10 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Grafychron Media Private Limited and Dr. Smiths Biotech Private Limited. Formerly with 2 companies, such as Cian Healthcare Limited. Engaged in General Business, Technology and more. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Grafychron Media Private Limited
U22300PN2022PTC211811
|
Director | 01 Jun 2022 | 2022 | Active |
Advacare Pharma Llp
AAM-5161
|
Designated Partner | 27 Apr 2018 | 2018 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Cian Healthcare Limited
L24233PN2003PLC017563
|
Cfo | 29 Jul 2016 | 2003 | Under Cirp |
Dr. Smiths Biotech Private Limited
U24246PN2015PTC154818
|
Director | 03 Jun 2019 | 2015 | Under Cirp |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Riyaz Bashir Khan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Riyaz Bashir Khan
Riyaz Bashir Khan has 10 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Grafychron Media Private Limited and Dr. Smiths Biotech Private Limited. Formerly with 2 companies, such as Cian Healthcare Limited. Engaged in General Business, Technology and more. Contributes to corporate operations.
Riyaz Bashir Khan is associated with 2 companies as Director and Designated Partner.
Riyaz Bashir Khan has expertise in General Business, Technology and other sectors.
Riyaz Bashir Khan has 10 years in corporate governance.